The need to accessorize: Molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle

Frontiers in Microbiology

Volumn 4, Issue SEP, 2013, Pages

  Anupam, Rajaneesh ^a   Doueiri, Rami ^a   Green, Patrick L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Accessory proteins; HTLV 1; HTLV 2; P28; P30

Indexed keywords

COMPLEMENTARY DNA; GAG PROTEIN; MESSENGER RNA; PROTEIN P28; PROTEIN P30; REX PROTEIN; TAX PROTEIN; TOLL LIKE RECEPTOR 4; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

CELL CYCLE REGULATION; DNA BINDING; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LIFE CYCLE STAGE; NONHUMAN; PATHOGENESIS; QUANTITATIVE ANALYSIS; REVIEW; SURVIVAL; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSFORMATION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 84885397869     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00275     Document Type: Review

References (80)

1. Araujo, A., and Hall, W. W. (2004). Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56, 10-19. doi:10.1002/ana.20126.
2. Arnold, J., Yamamoto, B., Li, M., Phipps, A. J., Younis, I., Lairmore, M. D., et al. (2006). Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107, 3976-3982. doi:10.1182/blood-2005-11-4551.
3. Arnold, J., Zimmerman, B., Li, M., Lairmore, M. D., and Green, P. L. (2008). Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T lymphocyte proliferation. Blood 112, 3788-3797. doi:10.1182/blood-2008-04-154286.
4. Anupam, R., Datta, A., Kesic, M., Green-Church, K., Shkriabai, N., Kvaratskhelia, M., et al. (2011). Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival. J. Biol. Chem. 286, 7661-7668. doi:10.1074/jbc.M110.176354.
5. Awasthi, S., Sharma, A., Wong, K., Zhang, J., Matlock, E. F., Rogers, L., et al. (2005). A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions. Mol. Cell. Biol. 25, 6178-6198. doi:10.1128/MCB.25.14.6178-6198.2005.
6. Bartoe, J. T., Albrecht, B., Collins, N. D., Robek, M. D., Ratner, L., Green, P. L., et al. (2000). Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74, 1094-1100. doi:10.1128/JVI.74.3.1094-1100.2000.
7. Baydoun, H., Duc-Dodon, M., Lebrun, S., Gazzolo, L., and Bex, F. (2007). Regulation of the human T-cell leukemia virus gene expression depends on the localization of regulatory proteins Tax, Rex, and p30II in specific nuclear subdomains. Gene 386, 191-201. doi:10.1016/j.gene.2006.09.008.
8. Baydoun, H. H., Pancewicz, J., Bai, X., and Nicot, C. (2010). HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol. Cancer 9, 302. doi:10.1186/1476-4598-9-302.
9. Baydoun, H. H., Pancewicz, J., and Nicot, C. (2011). Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood 117, 5897-5906. doi:10.1182/blood-2010-08-304600.
10. Bender, C., Rende, F., Cotena, A., Righi, P., Ronzi, P., Cavallari, I., et al. (2012). Temporal regulation of HTLV-2 expression in infected cell lines and patients:evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA. Retrovirology 9, 74. doi:10.1186/1742-4690-9-74.
11. Berneman, Z. N., Gartenhaus, R. B., Reitz, M. S., Blattner, W. A., Manns, A., Hanchard, B., et al. (1992). Expression of alternately spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. U.S.A. 89, 3005-3009. doi:10.1073/pnas.89.7.3005.
12. Busch, A., and Hertel, K. J. (2012). Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA 3, 1-12. doi:10.1002/wrna.100.
13. Caputi, M., and Zahler, A. M. (2002). SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J. 21, 845-855. doi:10.1093/emboj/21.4.845.
14. Chen, Y. M., Chen, S. H., Fu, C. Y., Chen, J. Y., and Osame, M. (1997). Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status. Int. J. Cancer 71, 196-202. doi:10.1002/(SICI)1097-0215(19970410)71:2<196::AID-IJC12>3.0.CO;2-G.
15. Ciminale, V., D'Agostino, D. M., Zotti, L., Franchini, G., Felber, B. K., and Chieco-Bianchi, L. (1995). Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 209, 445-456.doi:10.1006/viro.1995.1277.
16. Ciminale, V., Pavlakis, G. N., Derse, D., Cunningham, C. P., and Felber, B. K. (1992). Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses:novel mRNAs and proteins produced by HTLV type I. J. Virol. 66, 1737-1745.
17. Cockerell, G. L., Rovank, J., Green, P. L., and Chen, I. S. Y. (1996). A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood 87, 1030-1035.
18. D'Agostino, D. M., Ciminale, V., Zotti, L., Rosato, A., and Chieco-Bianchi, L. (1997). The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J. Virol. 71, 75-83.
19. Datta, A., Silverman, L., Phipps, A. J., Hiraragi, H., Ratner, L., and Lairmore, M. D. (2007). Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival. Retrovirology 4, 49. doi:10.1186/1742-4690-4-49.
20. Datta, A., Sinha-Datta, U., Dhillon, N. K., Buch, S., and Nicot, C. (2006). The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro-and anti-inflammatory cytokines from human macrophages. J. Biol. Chem. 281, 23414-23424. doi:10.1074/jbc.M600684200.
21. Derse, D., Mikovits, J., and Ruscetti, F. (1997). X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 237, 123-128. doi:10.1006/viro.1997.8781.
22. Doueiri, R., Anupam, R., Kvaratskhelia, M., Green, K. B., Lairmore, M. D., and Green, P. L. (2012). Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28:insights into difference in pathobiology of human retroviruses. Retrovirology 9, 64. doi:10.1186/1742-4690-9-64.
23. Draetta, G., and Eckstein, J. (1997). Cdc25 protein phosphatases in cell proliferation. Biochim. Biophys. Acta 1332, M53-M63.
24. Felber, B. K., Paskalis, H., Kleinman-Ewing, C., Wong-Staal, F., and Pavlakis, G. N. (1985). The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229, 675-679. doi:10.1126/science.2992082.
25. Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., and Mesnard, J. (2002). The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 76, 12813-12822. doi:10.1128/JVI.76.24.12813-12822.2002.
26. Gessain, A., Fretz, C., Koulibaly, M., Boudret, M. L., Bah, A., Raphael, M., et al. (1993). Evidence of HTLV-II infection in Guinea, West Africa. J. Acquir. Immune Defic. Syndr. 6, 324-325.
27. Ghorbel, S., Sinha-Datta, U., Dundr, M., Brown, M., Franchini, G., and Nicot, C. (2006). Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J. Biol. Chem. 281, 37150-37158. doi:10.1074/jbc.M603981200.
28. Goncalves, D. U., Proietti, F. A., Ribas, J. G., Araujo, M. G., Pinheiro, S. R., Guedes, A. C., et al. (2010). Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin. Microbiol. Rev. 23, 577-589. doi:10.1128/CMR.00063-09.
29. Goubau, P., Desmyter, J., Ghesquiere, J., and Kasereka, B. (1992). HTLV-II among pygmies. Nature 359, 201. doi:10.1038/359201a0.
30. Goubau, P., Liu, H. F., De Lange, G. G., Vandamme, A. M., and Desmyter, J. (1993). HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res. Hum. Retroviruses 9, 709-713. doi:10.1089/aid.1993.9.709.
31. Grassmann, R., Aboud, M., and Jeang, K. T. (2005). Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24, 5976-5985. doi:10.1038/sj.onc.1208978.
32. Halin, M., Douceron, E., Clerc, I., Journo, C., Ko, N. L., Landry, S., et al. (2009). Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 114, 2427-2438. doi:10.1182/blood-2008-09-179879.
33. Han, S. P., Tang, Y. H., and Smith, R. (2010). Functional diversity of the hnRNPs:past, present, and perspectives. Biochem. J. 430, 379-392. doi:10.1042/BJ20100396.
34. Heneine, W., Kaplan, J. E., Gracia, F., Lal, R., Levine, P. H., and Reeves, W. C. (1991). HTLV-II endemicity among Guaymi Indians in Panama. N. Engl. J. Med. 324, 565. doi:10.1056/NEJM199102213240815.
35. Hjelle, B., Scalf, R., and Swenson, S. (1990). High frequency of human T-cell leukemia/lymphoma virus type II infection in New Mexico blood donors:determination by sequence specific oligonucleotide hybridization. Blood 76, 450-454.
36. Iwanaga, M., Watanabe, T., and Yamaguchi, K. (2012). Adult T-cell leukemia:a review of epidemiological evidence. Front. Microbiol. 3:322. doi:10.3389/fmicb.2012.00322.
37. Jackson, S. P., and Bartek, J. (2009). The DNA-damage response in human biology and disease. Nature 461, 1071-1078. doi:10.1038/nature08467.
38. Jacobson, S., Mcfarlin, D. E., Robinson, S., Voskuhl, R., Martin, R., Brewah, A., et al. (1992). HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann. Neurol. 32, 651-657. doi:10.1002/ana.410320508.
39. Karkhanis, V., Hu, Y. J., Baiocchi, R. A., Imbalzano, A. N., and Sif, S. (2011). Versatility of PRMT5-induced methylation in growth control and development. Trends Biochem. Sci. 36, 633-641. doi:10.1016/j.tibs.2011.09.001.
40. Kiyokawa, T., Seiki, M., Iwashita, S., Imagawa, K., Shimizu, F., and Yoshida, M. (1985). p27xIII and p21xIII proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. U.S.A. 82, 8359-8363. doi:10.1073/pnas.82.24.8359.
41. Ko, N. L., Taylor, J. M., Bellon, M., Bai, X. T., Shevtsov, S. P., Dundr, M., et al. (2013). PA28gamma is a novel corepressor of HTLV-1 replication and controls viral latency. Blood 121, 791-800. doi:10.1182/blood-2012-03-420414.
42. Koralnik, I. J., Fullen, J., and Franchini, G. (1993). The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 67, 2360-2366.
43. Koralnik, I. J., Gessain, A., Klotman, M. E., Lo Monico, A., Berneman, Z. N., and Franchini, G. (1992). Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. U.S.A. 89, 8813-8817. doi:10.1073/pnas.89.18.8813.
44. Lairmore, M. D., Haines, R., and Anupam, R. (2012). Mechanisms of human T-lymphotropic virus type 1 transmission and disease. Curr. Opin. Virol. 2, 474-481. doi:10.1016/j.coviro.2012.06.007.
45. Lairmore, M. D., Jacobson, S., Gracia, F., De, B. K., Castillo, L., Larreategui, M., et al. (1990). Isolation of human T-cell lymphotropic virus type 2 from Guaymi indians in Panama. Proc. Natl. Acad. Sci. U.S.A. 87, 8840-8844. doi:10.1073/pnas.87.22.8840.
46. Levine, P. H., Jacobson, S., Elliott, R., Cavallero, A., Colclough, G., Dorry, C., et al. (1993). HTLV-II infection in Florida Indians. AIDS Res. Hum. Retroviruses 9, 123-127. doi:10.1089/aid.1993.9.123.
47. Li, M., and Green, P. L. (2007). Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J. Virol. Methods 142, 159-168. doi:10.1016/j.jviromet.2007.01.023.
48. Matsuoka, M., and Jeang, K. T. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270-280. doi:10.1038/nrc2111.
49. McKinnon, P. J. (2009). DNA repair deficiency and neurological disease. Nat. Rev. Neurosci. 10, 100-112. doi:10.1038/nrn2559.
50. Michael, B., Nair, A. M., Datta, A., Hiraragi, H., Ratner, L., and Lairmore, M. D. (2006). Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. Virology 354, 225-239. doi:10.1016/j.virol.2006.07.002.
51. Michael, B., Nair, A. M., Hiraragi, H., Shen, L., Feuer, G., Boris-Lawrie, K., et al. (2004). Human T lymphotropic virus type 1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 1, 39. doi:10.1186/1742-4690-1-39.
52. Nicot, C., Dundr, J. M., Johnson, J. R., Fullen, J. R., Alonzo, N., Fukumoto, R., et al. (2004). HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 10, 197-201. doi:10.1038/nm984.
53. Pique, C., Ureta-Vidal, A., Gessain, A., Chancerel, B., Gout, O., Tamouza, R., et al. (2000). Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191, 567-572. doi:10.1084/jem.191.3.567.
54. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A. 77, 7415-7419. doi:10.1073/pnas.77.12.7415.
55. Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C., and Murphy, E. L. (2005). Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058-6068. doi:10.1038/sj.onc.1208968.
56. Rende, F., Cavallari, I., Corradin, A., Silic-Benussi, M., Toulza, F., Toffolo, G. M., et al. (2011). Kinetics and intracellular compartmentalization of HTLV-1 gene expression:nuclear retention of HBZ mRNAs. Blood 117, 4855-4859. doi:10.1182/blood-2010-11-316463.
57. Robek, M., Wong, F., and Ratner, L. (1998). Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 72, 4458-4462.
58. Robek, M. D., and Ratner, L. (1999). Immortalization of CD4+ and CD8+ T-lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73, 4856-4865.
59. Rosin, R., Koch, C., Schmitt, I., Semmes, O. J., Jeang, K.-T., and Grassmann, R. (1998). A human T-cell leukemia virus Tax variant incapable of activating NF-κB retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 273, 6698-6703. doi:10.1074/jbc.273.12.6698.
60. Ross, T. M., Narayan, M., Fang, Z. Y., Minella, A. C., and Green, P. L. (2000). Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NF-κB or CREB/ATF activation fail to transform primary human T-cells. J. Virol. 74, 2655-2662. doi:10.1128/JVI.74.6.2655-2662.2000.
61. Seiki, M., Inoue, J., Takeda, T., and Yoshida, M. (1986). Direct evidence that p40xI of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J. 5, 561-565.
62. Silverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L., and Lairmore, M. D. (2004). Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication:evidence of in vivo reversion. J. Virol. 78, 3837-3845. doi:10.1128/JVI.78.8.3837-3845.2004.
63. Simonis, N., Rual, J. F., Lemmens, I., Boxus, M., Hirozane-Kishikawa, T., Gatot, J. S., et al. (2012). Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology 9, 26. doi:10.1186/1742-4690-9-26.
64. Simpson, J. C., Wellenreuther, R., Poustka, A., Pepperkok, R., and Wiemann, S. (2000). Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 1, 287-292. doi:10.1093/embo-reports/kvd058.
65. Sinha-Datta, U., Datta, A., Ghorbel, S., Dodon, M. D., and Nicot, C. (2007). Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J. Biol. Chem. 282, 14608-14615. doi:10.1074/jbc.M611219200.
66. Smith, M. R., and Greene, W. C. (1990). Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4, 1875-1885. doi:10.1101/gad.4.11.1875.
67. Takatsuki, K. (2005). Discovery of adult T-cell leukemia. Retrovirology 2, 16. doi:10.1186/1742-4690-2-16.
68. Taylor, J. M., Ghorbel, S., and Nicot, C. (2009). Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics 10:311. doi:10.1186/1471-2164-10-311.
69. Valeri, V. W., Hryniewicz, A., Andresen, V., Jones, K., Fenizia, C., Bialuk, I., et al. (2010). Requirement of the human T-cell leukemia virus p12 and p30 genes for infectivity of human dendritic cells and macaques but not rabbits. Blood 116, 3809-3817. doi:10.1182/blood-2010-05-284141.
70. Van Prooyen, N., Gold, H., Andresen, V., Schwartz, O., Jones, K., Ruscetti, F., et al. (2010). Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc. Natl. Acad. Sci. U.S.A. 107, 20738-20743. doi:10.1073/pnas.1009635107.
71. Vermeulen, K., Van Bockstaele, D. R., and Berneman, Z. N. (2003). The cell cycle:a review of regulation, deregulation, and therapeutic targets in cancer. Cell Prolif. 36, 131-149. doi:10.1046/j.1365-2184.2003.00266.x.
72. Wang, L., Pal, S., and Sif, S. (2008). Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol. Cell. Biol. 28, 6262-6277. doi:10.1128/MCB.00923-08.
73. Yamamoto, B., Li, M., Kesic, M., Younis, I., Lairmore, M. D., and Green, P. L. (2008). Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo. Retrovirology 5, 38. doi:10.1186/1742-4690-5-38.
74. Yoshida, M. (2005). Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24, 5931-5937. doi:10.1038/sj.onc.1208981.
75. Yoshida, M., Miyoshi, I., and Hinuma, Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U.S.A. 79, 2031-2035. doi:10.1073/pnas.79.6.2031.
76. Younis, I., Boris-Lawrie, K., and Green, P. L. (2006). Human T-cell leukemia virus ORF II p28 encodes a post-transcriptional repressor that is recruited at the level of transcription. J. Virol. 80, 181-191. doi:10.1128/JVI.80.1.181-191.2006.
77. Younis, I., and Green, P. L. (2005). The human T-cell leukemia virus Rex protein. Front. Biosci. 10:431-445. doi:10.2741/1539.
78. Younis, I., Khair, L., Dundr, M., Lairmore, M. D., Franchini, G., and Green, P. L. (2004). Repression of human T-cell leukemia virus type 1 and 2 replication by a viral mRNA-encoded posttranscriptional regulator. J. Virol. 78, 11077-11083. doi:10.1128/JVI.78.20.11077-11083.2004.
79. Zhang, W., Nisbet, J. W., Albrecht, B., Ding, W., Kashanchi, F., Bartoe, J. T., et al. (2001). Human T-lymphotropic virus type 1 p30II regulates gene transcription by binding CREB binding protein/p300. J. Virol. 75, 9885-9895. doi:10.1128/JVI.75.20.9885-9895.2001.
80. Zhang, W., Nisbet, J. W., Bartoe, J. T., Ding, W., and Lairmore, M. D. (2000). Human T-lymphotropic virus type 1 p30II functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 74, 11270-11277. doi:10.1128/JVI.74.23.11270-11277.2000.